Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian D Davis

Showing results (81-90 of 281) with videos related to

Pageof 29
Sort By:
Immunology and Cell Biology|May 10, 2006
Directions in the immune targeting of cancer: lessons learned from the cancer-testis Ag NY-ESO-1Theo Nicholaou, Lisa Ebert, Ian D Davis, et al.
Cancer Chemotherapy and Pharmacology|December 6, 2005
A phase 1 and pharmacokinetic study of gemcitabine and oxaliplatin in patients with solid tumorsHui K Gan, Paul L Mitchell, Peter Galettis, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 24, 2018
Exploring the spectrum of late effects following radical orchidectomy for stage I testicular seminoma: a systematic review of the literatureJennifer A Soon, Angelyn Anton, Javier Torres, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Interleukin-21 signaling: functions in cancer and autoimmunityIan D Davis, Kresten Skak, Mark J Smyth, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|July 6, 2016
Fully automated synthesis of [(18) F]fluoro-dihydrotestosterone ([(18) F]FDHT) using the FlexLab moduleUwe Ackermann, Jason S Lewis, Kenneth Young, et al.
Plos One|November 9, 2022
Experiences of participants in a clinical trial of a novel radioactive treatment for advanced prostate cancer: A nested, qualitative longitudinal studyBianca Viljoen, Michael S Hofman, Suzanne K Chambers, et al.
BMC Cancer|May 28, 2015
BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301)Dickon Hayne, Martin Stockler, Steve P McCombie, et al.
BMJ Open|February 19, 2018
Experiences of Australian men diagnosed with advanced prostate cancer: a qualitative studySuzanne K Chambers, Melissa K Hyde, Kirstyn Laurie, et al.
Asia-Pacific Journal of Clinical Oncology|April 28, 2018
Interpolation to define clinical tumor stage in prostate cancer using clinical description of digital rectal examinationSue M Evans, Declan G Murphy, Ian D Davis, et al.
Blood|March 22, 2003
ATP gradients inhibit the migratory capacity of specific human dendritic cell types: implications for P2Y11 receptor signalingMax Schnurr, Tracey Toy, Patrizia Stoitzner, et al.
Pageof 29

Showing results (81-90 of 281) with videos related to

Sort By:
Pageof 29
Immunology and Cell Biology|May 10, 2006
Directions in the immune targeting of cancer: lessons learned from the cancer-testis Ag NY-ESO-1Theo Nicholaou, Lisa Ebert, Ian D Davis, et al.
Cancer Chemotherapy and Pharmacology|December 6, 2005
A phase 1 and pharmacokinetic study of gemcitabine and oxaliplatin in patients with solid tumorsHui K Gan, Paul L Mitchell, Peter Galettis, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 24, 2018
Exploring the spectrum of late effects following radical orchidectomy for stage I testicular seminoma: a systematic review of the literatureJennifer A Soon, Angelyn Anton, Javier Torres, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Interleukin-21 signaling: functions in cancer and autoimmunityIan D Davis, Kresten Skak, Mark J Smyth, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|July 6, 2016
Fully automated synthesis of [(18) F]fluoro-dihydrotestosterone ([(18) F]FDHT) using the FlexLab moduleUwe Ackermann, Jason S Lewis, Kenneth Young, et al.
Plos One|November 9, 2022
Experiences of participants in a clinical trial of a novel radioactive treatment for advanced prostate cancer: A nested, qualitative longitudinal studyBianca Viljoen, Michael S Hofman, Suzanne K Chambers, et al.
BMC Cancer|May 28, 2015
BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301)Dickon Hayne, Martin Stockler, Steve P McCombie, et al.
BMJ Open|February 19, 2018
Experiences of Australian men diagnosed with advanced prostate cancer: a qualitative studySuzanne K Chambers, Melissa K Hyde, Kirstyn Laurie, et al.
Asia-Pacific Journal of Clinical Oncology|April 28, 2018
Interpolation to define clinical tumor stage in prostate cancer using clinical description of digital rectal examinationSue M Evans, Declan G Murphy, Ian D Davis, et al.
Blood|March 22, 2003
ATP gradients inhibit the migratory capacity of specific human dendritic cell types: implications for P2Y11 receptor signalingMax Schnurr, Tracey Toy, Patrizia Stoitzner, et al.
Pageof 29